Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans

  • Anna T. Tillmann,

    Current address: Institute of Healthy Ageing, and GEE, University College London, London, United Kingdom.

    Affiliation Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Karin Strijbis,

    Current address: Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, Netherlands.

    Affiliation Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Gary Cameron,

    Affiliation Division of Applied Medicine, Mass Spectrometry Section, University of Aberdeen, Aberdeen, United Kingdom

  • Elahe Radmaneshfar,

    Affiliation Institute for Complex Systems and Mathematical Biology, SUPA, University of Aberdeen, Aberdeen, United Kingdom

  • Marco Thiel,

    Affiliation Institute for Complex Systems and Mathematical Biology, SUPA, University of Aberdeen, Aberdeen, United Kingdom

  • Carol A. Munro,

    Affiliation Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Donna M. MacCallum,

    Affiliation Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Ben Distel,

    Affiliation Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Neil A. R. Gow,

    Affiliation Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Alistair J. P. Brown

    al.brown@abdn.ac.uk

    Affiliation Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans

  • Anna T. Tillmann, 
  • Karin Strijbis, 
  • Gary Cameron, 
  • Elahe Radmaneshfar, 
  • Marco Thiel, 
  • Carol A. Munro, 
  • Donna M. MacCallum, 
  • Ben Distel, 
  • Neil A. R. Gow, 
  • Alistair J. P. Brown
PLOS
x

Abstract

The major fungal pathogen of humans, Candida albicans, is exposed to reactive nitrogen and oxygen species following phagocytosis by host immune cells. In response to these toxins, this fungus activates potent anti-stress responses that include scavenging of reactive nitrosative and oxidative species via the glutathione system. Here we examine the differential roles of two glutathione recycling enzymes in redox homeostasis, stress adaptation and virulence in C. albicans: glutathione reductase (Glr1) and the S-nitrosoglutathione reductase (GSNOR), Fdh3. We show that the NADPH-dependent Glr1 recycles GSSG to GSH, is induced in response to oxidative stress and is required for resistance to macrophage killing. GLR1 deletion increases the sensitivity of C. albicans cells to H2O2, but not to formaldehyde or NO. In contrast, Fdh3 detoxifies GSNO to GSSG and NH3, and FDH3 inactivation delays NO adaptation and increases NO sensitivity. C. albicans fdh3⎔ cells are also sensitive to formaldehyde, suggesting that Fdh3 also contributes to formaldehyde detoxification. FDH3 is induced in response to nitrosative, oxidative and formaldehyde stress, and fdh3Δ cells are more sensitive to killing by macrophages. Both Glr1 and Fdh3 contribute to virulence in the Galleria mellonella and mouse models of systemic infection. We conclude that Glr1 and Fdh3 play differential roles during the adaptation of C. albicans cells to oxidative, nitrosative and formaldehyde stress, and hence during the colonisation of the host. Our findings emphasise the importance of the glutathione system and the maintenance of intracellular redox homeostasis in this major pathogen.

Introduction

The major fungal pathogen, Candida albicans, has the capacity to colonise diverse niches in its human host. This fungus is part of the microflora of the skin, mouth, gut and urogenital tracts of humans. C. albicans is a frequent cause of mucosal infections (thrush) in otherwise healthy individuals, with most women suffering at least one episode of vaginitis in their lifetime. C. albicans is also the most common fungal species responsible for life-threatening hospital-acquired bloodstream infections in immunocompromised patients [13].

The ability of C. albicans to thrive in diverse niches is dependent upon its robust adaptive responses to the local environmental stresses encountered in these niches. For example, immune cells such as macrophages combat microbial infection by exposing invading microbes to a battery of insults that include reactive nitrogen species (RNS), reactive oxygen species (ROS) and cationic fluxes [46]. Macrophages have been reported to generate up to 57 μM nitric oxide [7] and up to 14 mM hydrogen peroxide (H2O2) [8,9], although estimating the levels of specific ROS species during the oxidative burst is challenging [10,11]. Cation concentrations are around 150 mM in human blood, have been reported reach 0.2–0.3 M in phagocytes [5] and can increase to 600 mM in the kidney [12]. Therefore, C. albicans cells are exposed to significant oxidative, nitrosative and cationic stresses during host colonization and invasion [1315].

Glutathione (L-γ-glutamylcysteinylglycine; GSH), the most abundant non-protein thiol in eukaryotic cells, plays a major role in protective responses to oxidative and nitrosative stress. Glutathione reacts with reactive oxygen and nitrogen species to generate glutathione adducts, such as glutathione disulphide (GSSG) and S-nitrosoglutathione (GSNO). In addition to detoxifying xenobiotics and free radicals, glutathione functions as a co-factor in many enzymatic reactions and is involved in amino acid transport and signalling [16,17]. S-glutathionylation protects protein thiols from irreversible over-oxidation [18]. Glutathione maintains intracellular redox homeostasis through the oxidation of its cysteine sulphydryl moiety and disulphide bond formation [19]. The low redox potential of glutathione (E = -240 mV), combined with its high intracellular concentration (1–10 mM), contribute to its large redox buffering capacity [20,21]. Fungal genes involved in both glutathione synthesis and the recycling of GSSG and GSNO are tightly regulated in response to stress exposure [21,22].

Glutathione is synthesised in two ATP-dependent steps. In the first rate-limiting step, γ-glutamylcysteine synthetase (Gsh1 in S. cerevisiae) ligates glutamate and cysteine to form the dipeptide γ-glutamylcysteine [23]. In the second enzymatic step glutathione synthetase (Gsh2 in S. cerevisiae) converts γ-glutamylcysteine and glycine into glutathione [24]. In S. cerevisiae, Gsh1 catalyses the rate-limiting step in GSH synthesis and GSH1 deletion significantly increases the intracellular redox potential to -178 mV, compared with -235 mV in wild type cells [25]. Consequently, S. cerevisiae gsh1 cells are sensitive to oxidative stress. This mutant also displays growth defects on minimal medium in the absence of stress [23], a phenotype that can be suppressed by the addition of exogenous GSH [26]. These results indicate that GSH is an essential metabolite for the growth of S. cerevisiae. Exogenous GSH also confers protection against oxidative stresses mediated by disulfiram [27], hypochlorite, chlorite [28] and heavy metals [29]. In C. albicans, the deletion of GCS1 (the homologue of S. cerevisiae GSH1) causes cells to upregulate typical apoptotic markers, reduces their resistance to killing by human macrophages and decreases their virulence in a murine model of disseminated candidiasis [30], [31]. These observations highlight the importance of glutathione in general and for C. albicans pathogenicity in particular.

Following the formation of glutathione adducts, such as GSSG and GSNO, these molecules are recycled to reform glutathione via glutathione reductase and S-nitrosoglutathione reductase (GSNOR). In S. cerevisiae, glutathione reductase (Glr1), a member of the FAD-containing pyridine disuphide oxidoreductase family, is required for protection against oxidative stress [32]. It reduces GSSG in an NADPH-dependent manner following the reaction: GSSG + NADPH + H+ → 2GSH + NADP+. Thus while detoxifying GSSG, Glr1 concomitantly lowers the intracellular NADPH/NADP+ ratio [33]. Glr1 is not essential in S. cerevisiae since thioredoxins, Trx1 and Trx2, can detoxify GSSG to GSH in the absence of Glr1 [34]. Indeed, Drosophila and trypanosomes do not encode glutathione reductases, but detoxify GSSG via the thioredoxin or trypanothione systems, respectively [35,36].

Glutathione-dependent formaldehyde reductases (GSNORs) are conserved from bacteria to humans [21,37], suggesting that GSNORs perform important functions in all living organisms. These enzymes not only regulate GSNO levels, but are also involved in the repair of S-nitrosylated proteins [37]. Consequently, S. cerevisiae cells lacking GSNOR (the sfa1 mutant) display slow adaptation to nitrosative stress, but are not sensitive to oxidative stress [37]. GSNORs are GSH-dependent bi-functional enzymes that are able to reduce GSNO to form GSSG plus NH3, as well as detoxifying formaldehyde [37]. In plants, GSNOR modulates the extent of cellular S-nitrosothiol (SNO) formation following nitrosative stress and is required for disease resistance [38].

Despite the importance of glutathione and redox homeostasis for oxidative stress resistance and virulence in C. albicans, the relative contributions of Glr1 and GSNOR in glutathione recycling have not been examined in this fungus. Indeed, a GSNOR has not previously been identified in C. albicans. Therefore, we have examined the roles of Glr1 and GSNOR in C. albicans. We show that these enzymes are crucial for the maintainance of redox homeostasis in C. albicans and that they contribute to the virulence of this major fungal pathogen.

Results

The C. albicans genome encodes a putative glutathione reductase and an S-nitrosoglutathione reductase

A single glutathione reductase gene has been annotated in the C. albicans genome on the basis of its sequence similarity to glutathione reductases (GRs) from other species [39]. C. albicans GLR1 (C5_01520C) encodes a highly conserved NADPH-dependent glutathione reductase (S1 Fig) [40] that carries the classical NADH and FAD binding domains and dimerization domain of GRs (Fig 1A). Phylogenetically, C. albicans Glr1 is most closely related to GRs from other fungi, displaying 66% amino acid sequence identity to S. cerevisiae Glr1 (Fig 1B). Fungal GRs cluster with human, mouse and Caenorhabditis elegans GRs, clearly separable from GSNORs from the same organisms (Fig 1B).

thumbnail
Fig 1. C. albicans Glr1 and Fdh3 belong to evolutionary conserved families of glutathione reductases (GRs) and S-nitroso-glutathione reductases (GSNORs), respectively.

(A) The functional domains of GSH-dependent formaldehyde dehydrogenases class III (GSNORs) and NADPH-dependent glutathione reductases (GRs). GSNORs harbour a catalytic domain (ADH), an NAD(H) binding domain, and a dimerization domain. GRs have an NADH- and FAD-binding domains and a dimerization domain. (B) Phylogenetic tree of GSNOR- and GR-related proteins generated using ClustalW: homologs are presented from Candida albicans (CaFdh3, CaGlr1), Saccharomyces cerevisiae (ScSfa1, ScGlr1), Schizosaccharomyces pombe (SpSPCC13B11.04c, SpPgr1), Mus musculus (MsAdh5; MsGsr1), Homo sapiens (HsAdh5; HsGsr), Drosophila melanogaster (DmFdh) and Caenorhabditis elegans (CeH24K24.3; CeGsr-1). Structures are presented for human liver ChiChi alcohol dehydrogenase (protein data bank (pdb) accession code 1TEH; a GSNOR that has 65% sequence identity to CaFdh3p), and S. cerevisiae Glr1 (pdb accession code 2HQM; a GR with 66% sequence identity to CaGlr1p). Structure representations were made with PyMOL (http://www.pymol.org).

https://doi.org/10.1371/journal.pone.0126940.g001

C. albicans also contains a single GSNOR gene, FDH3 (CR_10250C_A) [39]. Based on its sequence similarity to GSNORs from other organisms (S2 Fig), FDH3 appears to encode a GSH-dependent formaldehyde dehydrogenase class III that contains alcohol dehydrogenase-like, NADH binding and dimerization domains (Fig 1A). GSNORs are highly conserved from bacteria to man [21]. Indeed, the sequence of C. albicans Fdh3 is 65% identical to human liver ChiChi alcohol dehydrogenase (Hs Adh5) (Fig 1B), which is a GSH-dependent formaldehyde dehydrogenase.

C. albicans Fdh3 and Glr1 play differential roles in conferring formaldehyde, nitrosative and oxidative stress resistance

GSNOR is the only enzyme so far characterised that enzymatically detoxifies GSNO [21], and both GSNOR and GR are critical for the maintenance of the glutathione redox balance under nitrosative and oxidative stress [21]. In C. albicans, Glr1 is presumed to act as a GR [39], and we reasoned that Fdh3 might act as the GSNOR, detoxifying GSNO and catalysing the detoxification of formaldehyde (CH2O) to formate (CHOO-) (Fig 2).

thumbnail
Fig 2. Predicted roles for Fdh3 and Glr1 in C. albicans.

(A) Predicted roles for Fdh3 and Glr1 in GSNO and GSSG detoxification. A shows the working hypothesis of the major enzymes involved in the detoxification of GSSG (glutathione disulphide) and GSNO (S-nitrosoglutathione). When glutathione (GSH) is oxidised via H2O2 to GSSG, GSSG can be reduced with the help of the NADPH-dependent glutathione reductase (GR). We predict that the glutathione reductase of Candida albicans is GLR1. When GSH is exposed to NO, GSH is S-nitrosylated to GSNO. We predict that the S-nitrosoglutathione reductase (GSNOR) of Candida albicans is FDH3. (B) Predicted role for Fdh3 in formaldehyde detoxification. B shows the second enzymatic function of GSNOR the detoxification of formaldehyde. Formaldehyde reacts with glutathione (GSH) to form S-(hydroxmethyl)glutathione which then gets converted by Fdh3 and NAD+ to S-(formyl)glutathione.

https://doi.org/10.1371/journal.pone.0126940.g002

To test these predictions we constructed C. albicans glr1Δ and fdh3Δ null mutants, and then reintegrated wild type GLR1 and FDH3 genes to generate isogenic control strains. As predicted, the glr1Δ mutant was sensitive to hydrogen peroxide (7.5 mM), a phenotype that was suppressed by reintegration of GLR1. The glr1Δ mutant was resistant to formaldehyde (5 mM) (Fig 3A). In contrast, the fdh3Δ mutant was resistant to hydrogen peroxide, but sensitive to formaldehyde (Fig 3A and 3B). Reintegration of FDH3 suppressed this sensitivity, confirming that Fdh3 is critical for formaldehyde resistance. These observations were consistent with the predicted differential roles for Fdh3 and Glr1 in the detoxification of formaldehyde and peroxide-induced GSSG, respectively.

thumbnail
Fig 3. Differential sensitivities of C. albicans fdh3Δ and glr1Δ cells to hydrogen peroxide, nitric oxide and formaldehyde.

(A) Sensitivity to hydrogen peroxide (7.5 mM H2O2) and formaldehyde (5 mM CH2O): wild type (CPK05); glr1Δ (CKS10), glr1Δ+GLR1 (CKS31), fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4) (Table 1). (B) Dose-dependent sensitivity to formaldehyde: wild type (CPK05); fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4). (C) Differences in adaptation (inflection) time after nitrosative stress (2.5 mM DPTA NONOate): wild type (CPK05); glr1Δ (CKS10); glr1Δ+GLR1 (CKS31); fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4).

https://doi.org/10.1371/journal.pone.0126940.g003

We also investigated the impact of inactivating Fdh3 or Glr1 on the resistance of C. albicans cells to nitrosative stress (2.5 mM DPTA NONOate). As predicted (Fig 2), fdh3Δ cells were relatively sensitive to nitrosative stress, taking significantly longer than wild type cells to adapt to this stress (Fig 3C). Taken together, our data are consistent with the idea that the Fdh3 is a bi-functional enzyme involved in the detoxification of both formaldehyde and GSNO.

Surprisingly, glr1Δ cells were relatively resistant to nitrosative stress, adapting more quickly to DPTA NONOate than the wild type and GLR1 reintegrant control strains (Fig 3C). To examine the basis for this we tested the impact of GLR1 or FDH3 deletion upon the expression of each mRNA by qRT-PCR (Fig 4). As expected, the GLR1 and FDH3 mRNAs were not detectable in their respective mutant strains. GLR1 mRNA levels were reduced about 4-fold in fdh3Δ cells, relative to the wild type control. However, FDH3 mRNA levels were elevated about 2.5-fold in glr1Δ cells (Fig 4). This increased FDH3 expression could account for the increased nitrosative stress resistance of the glr1Δ strain (Fig 3C).

thumbnail
Fig 4. Effect of FDH3 and GLR1 deletion on basal gene expression.

Quantification of FDH3 and GLR1 mRNA levels by qRT-PCR, relative to the internal ACT1 mRNA control and normalised to wild type cells: wild type (BWP17); fdh3Δ (ATT1); glr1Δ (CKS10).

https://doi.org/10.1371/journal.pone.0126940.g004

Impact of Fdh3 and Glr1 deletion upon gene expression

The deletion of either FDH3 or GLR1 affects the expression of the other gene under basal conditions in the absence of stress (Fig 4). Therefore, we reasoned that the expression of these genes might also be perturbed in glr1Δ and fdh3Δ cells following exposure to oxidative, and nitrosative or formaldehyde stress. To test this we measured the expression levels of selected genes involved in stress defence by qRT-PCR, relative to the ACT1 mRNA internal control, following a 10 min exposure to 5 mM H2O2, 2.5 mM CySNO or 5 mM formaldehyde. GLR1 is known to be induced in response to oxidative stress [41], and therefore we examined its expression in response to these stresses in wild type and fdh3Δ cells (Fig 5A). The GLR1 mRNA was up-regulated in response to oxidative and nitrosative stress, but was down-regulated following formaldehyde stress. Deletion of FDH3 had a minimal effect upon this expression profile, except that GLR1 expression was no longer reduced in response to formaldehyde stress. FDH3 displayed a similar expression profile to GLR1 in wild type cells (Fig 5B). FDH3 was up-regulated following exposure to both oxidative and nitrosative stress, and down-regulated following formaldehyde stress. This regulation was perturbed in glr1Δ cells, primarily because basal FDH3 mRNA levels were increased in the absence of stress, which was consistent with our previous observations (Fig 4).

thumbnail
Fig 5. Impact of FDH3 and GLR1 deletion on transcript levels in respose to formaldehyde, oxidative or nitrosative stress.

Transcript levels were quantified by qRT-PCR, relative to the internal ACT1 mRNA control after 10 min of stress treatment and normalised to untreated wild type cells: wild type (CPK05); fdh3Δ (ATT1); glr1Δ (CKS10). Stresses were 2.5 mM CySNO (NS), 5 mM CH2O or 5 mM H2O2 (XS). Gene expression was assayed for the following genes: (A) GLR1, (B) FDH3, (C) TRX1, (D) PDI1.

https://doi.org/10.1371/journal.pone.0126940.g005

We also examined the mRNA levels for TRX1 (thioredoxin) under equivalent conditions (Fig 5C). As reported previously [4143], TRX1 was induced in response to oxidative and nitrosative stress. Interestingly, the response to oxidative stress was unaffected in fdh3Δ cells, but the response to nitrosative stress was attenuated. This is consistent with the idea that in the absence of Fdh3, GSSG generation might be reduced following nitrosative stress (Fig 2). In glr1Δ cells, but not in fdh3Δ cells, TRX1 was strongly induced in response to formaldehyde stress (Fig 5C). This supports the hypothesis that intracellular GSSG levels might accumulate following formaldehyde stress in cells that lack Glr1, but contain Fdh3 (Fig 2).

Protein disulphide-isomerase is involved in redox-dependent protein folding, and therefore we also investigated PDI1 mRNA levels under conditions where GSSG levels probably rise significantly (Fig 5D). Consistent with results found for TRX1, PDI1 expression was strongly induced in glr1Δ cells, but not in fdh3Δ cells, after formaldehyde exposure.

Effect of Glr1 and Fdh3 inactivation upon GSSG and GSNO detoxification

The data obtained are consistent with the predicted roles for Glr1 and Fdh3 in GSSG and GSNO detoxification (Fig 2). We then tested these predictions directly by examining the impact of deleting GLR1 or FDH3 upon GSSG and GSNO detoxification rates.

GSSG detoxification was assayed by LC-MS/MS. GSSG detoxification rates were minimal in the absence of protein extract (buffer alone), but the majority of GSSG was detoxified within 10 min by wild type protein extracts (Fig 6A). Deletion of GLR1 completely blocked GSSG detoxification rates, and these rates were restored by reintegration of the wild type GLR1 gene. GSSG detoxification rates were also reduced in fdh3Δ cells, which could be due to the 4-fold reduction in GLR1 expression in these cells (Fig 4). We conclude that GLR1 is essential for rapid GSSG detoxification in C. albicans, which is consistent with the view that this gene does indeed encode a glutathione reductase.

thumbnail
Fig 6. Lack of Fdh3 or Glr1 affects GSSG and GSNO detoxification and the glutathione redox potential.

(A) GSSG detoxification by protein extracts from wild type (CPK05), glr1Δ (CKS10), glr1Δ+GLR1 (CKS31), fdh3Δ (ATT1) and fdh3Δ+FDH3 (ATT4) cells. (B) GSNO detoxification by protein extracts from wild type (CPK05), glr1Δ (CKS10), glr1Δ+GLR1 (CKS31), fdh3Δ (ATT1) and fdh3Δ+FDH3 (ATT4) cells. (C) Glutathione redox potential for wild type (CPK05), glr1Δ (CKS10), glr1Δ+GLR1 (CKS31), fdh3Δ (ATT1) and fdh3Δ+FDH3 (ATT4) strains.

https://doi.org/10.1371/journal.pone.0126940.g006

GSNO detoxification was also assayed in wild-type and mutant cells (Fig 6B). As expected (Fig 2), GLR1 inactivation had no major effect upon GSNO detoxification, whereas rates of GSNO detoxification were reduced in fdh3Δ cells (Fig 6B). However, GSNO detoxification was not completely blocked following Fdh3 deletion, suggesting that other C. albicans enzymes, in addition to Fdh3, must have denitrosylation or trans-nitrosylation activity. The identity of these enzymes remains to be determined.

Given the impact of Glr1 inactivation upon GSSG detoxification in particular, the glr1Δ mutation is likely to perturb redox homeostasis in C. albicans cells. The GSSG/GSH redox potential (ΔE), which essentially reflects the relative amounts of reduced versus oxidized glutathione, was measured in mutant and wild type cells (Fig 6C). The GSSG/GSH redox potential of C. albicans fdh3Δ cells displayed no significant difference from wild type or FDH3 reintegrant controls, despite the reduced ability of this mutant to detoxify GSSG (Fig 6A). However, the GSSG/GSH redox potential of glr1Δ cells was significantly elevated, which correlated with their inability to detoxify GSSG (Fig 6A and 6C). Indeed, the redox potential of glr1Δ cells was close to the value of -180 mV, which has been associated with cell death in other systems [20,44]. This was consistent with the relatively slow growth of glr1Δ colonies (Fig 1A).

Both FDH3 and GLR1 influence C. albicans virulence

The above data support the hypothesis that Glr1 is a glutathione reductase playing a critical role in the detoxification of GSSG and maintenance of redox homeostasis in C. albicans, and that Fdh3 is a bi-functional enzyme playing critical roles in detoxification of GSNO and formaldehyde (Fig 2). Given the importance of oxidative and nitrosative stress in C. albicans-phagocyte interactions during infection [45,46], we reasoned that changes in GLR1 and FDH3 functionality might affect the ability of C. albicans cells to kill phagocytes. To test this, we measured the percentage of cultured murine macrophages (RAW264.7 cells) that were killed by wild type and mutant C. albicans cells. The glr1Δ and fdh3Δ mutants displayed significantly reduced ability to kill macrophages when compared to the wild type and reintegrant controls (Fig 7). Furthermore, doxycycline-dependent overexpression of GLR1 or FDH3 from the tetON promoter [47,48] increased the ability of C. albicans to kill macrophages (Fig 7), when compared to the parental strain. We conclude that the functions of Glr1 and Fdh3, and their contribution to the maintenance of redox homeostasis, are integral to C. albicans viability and potency during fungus-phagocyte interactions.

thumbnail
Fig 7. Deletion or overexpression of GLR1 or FDH3 alters the ability of C. albicans to kill macrophages.

C. albicans deletion (Δ) and overexpression (O/E) mutants (1x106 cells) were co-incubated with RAW264.7 macrophages (2x105) for 3 h. The proportion of killed macrophages was determined following trypan blue staining: wild type (CPK05), glr1Δ (CKS10), glr1Δ+GLR1 (CKS31), fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4); WT+DOX, tetON-empty (CAMY203); GLR1+DOX, tetON-GLR1 (ATT6); FDH3+DOX, tetON-FDH3 (ATT7).

https://doi.org/10.1371/journal.pone.0126940.g007

Based on their effects during fungus-phagocyte interactions, it was conceivable that GLR1 and FDH3 might influence the virulence of C. albicans during systemic infection. This was first tested in the invertebrate wax moth (Galleria mellonella) larval infection model, which has been established as a suitable proxy for systemic infection of the mammalian host [49]. Wild type C. albicans cells killed more than 90% of larvae within two days (Fig 8A). The fdh3Δ cells displayed a small, but reproducible, statistically significant reduction in virulence, whilst deletion of GLR1 resulted in a much greater effect on virulence (Fig 8A). Doxycycline-induced overexpression of GLR1 and FDH3 dramatically increased the virulence of C. albicans (Fig 8B). Experiments utilising the overexpression mutants was performed with a reduced C. albicans inoculum to permit resolution of the increased virulence (1 x 104 cells versus 2.5 x 105 cells). These infection data are consistent with the macrophage killing assays (Fig 7) and show that both Glr1 and Fdh3 contribute to the virulence of C. albicans.

thumbnail
Fig 8. Virulence of C. albicans GLR1 and FDH3 mutants in the G. mellonella infection model.

Kaplan-Meier plots of G. mellonella survival after injection with C. albicans. (A) Analysis of deletion mutants using a dose of 2.5x105 C. albicans cells/larva: wild type (CPK05); glr1Δ (CKS10); glr1Δ+GLR1 (CKS31); fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4) (Table 1). (B) Analysis of overexpression mutants using a lower dose of 1x104 C. albicans cells/larva: WT+DOX, tetON-empty (CAMY203); GLR1+DOX, tetON-GLR1 (ATT6); FDH3+DOX, tetON-FDH3 (ATT7).

https://doi.org/10.1371/journal.pone.0126940.g008

Having established the impact of GLR1 and FDH3 on C. albicans virulence in the G. mellonella infection model, we then progressed to a mammalian model of systemic candidiasis. The virulence of the mutants was assayed using a three-day murine intravenous challenge model [50], which allows calculation of an outcome score. In this model, fdh3Δ cells displayed no significant difference in outcome score compared to the wild type and reintegrant controls (Fig 9A). However, the glr1Δ mutant showed a significant reduction in virulence. It is worth noting that Fdh3 inactivation had less of an impact than Glr1 inactivation upon virulence in the G. mellonella model (Fig 8A). This subtle effect might not have been detectable in the mouse experiments (Fig 9A).

thumbnail
Fig 9. Virulence of C. albicans GLR1 and FDH3 mutants in the murine model of systemic candidiasis.

Mice were infected with C. albicans strains by lateral tail vein injection, and infection outcome scores calculated after 72 h (Materials and Methods: means ± SEM; n = 6). (A) Analysis of deletion mutants: wild type (CPK05); glr1Δ (CKS10); glr1Δ+GLR1 (CKS31); fdh3Δ (ATT1); fdh3Δ+FDH3 (ATT4). (B) Analysis of overexpression mutants in mice +/- doxycycline (DOX) in their drinking water: WT, tetON-empty (CAMY203); GLR1, tetON-GLR1 (ATT6); FDH3, tetON-FDH3 (ATT7).

https://doi.org/10.1371/journal.pone.0126940.g009

We then examined the virulence of the GLR1 and FDH3 overexpression strains. We noted that the treatment of animals with doxycycline, which was required to induce GLR1 and FDH3 overexpression, resulted in increased outcome score for infection with the wild type C. albicans strain. Therefore, the virulence of the test strains was compared to this control (WT + DOX: Fig 9B). Once again, GLR1 overexpression resulted in increased virulence of C. albicans. However, for reasons that are not clear, FDH3 overexpression attenuated fungal virulence in this murine model of systemic infection. Whatever the molecular basis for this observation, it is clear that GLR1 and FDH3 functionality influences the virulence of C. albicans during systemic infection.

Discussion

Numerous studies support the view that robust oxidative stress responses contribute to the pathogenicity of the major fungal pathogen, C. albicans. For example, inactivation of certain regulators that contribute to oxidative stress adaptation, such as the AP-1-like transcription factor Cap1 and the stress activated protein kinase Hog1, affect C. albicans virulence, albeit only slightly in the case of Cap1 [5153]. Key enzymes involved in ROS detoxification, such as catalase (Cat1) and superoxide dismutase (Sod1, Sod5), are also essential for full virulence [13,5456]. In addition, C. albicans mutants lacking certain components of the glutaredoxin (Gcs1, Grx2) and thioredoxin systems (Trx1) or mitochondrial-associated stress functions (Goa1) display attenuated virulence [31,5759]. Therefore, we reasoned that key enzymes involved in the detoxification and recycling of glutathione adducts formed during oxidative stress are likely to be important for the maintenance of redox homeostasis in C. albicans and its virulence. When this work was initiated, we predicted that two annotated C. albicans genes might play key roles in GSSG and GSNO recycling. The first was Fdh3, a putative glutathione-dependent S-nitrosoglutathione reductase (GSNOR), which catalyses the generation of GSSG during the recycling of GSNO adducts. The second was a putative glutathione reductase (GR), Glr1, which was predicted to regenerate GSH from GSSG in an NADPH-dependent manner. Our bioinformatics analyses of C. albicans Glr1 and Fdh3 indicated that they are members of phylogenetically distinct GR and GSNOR families (Fig 1, and S1 and S2 Figs). We also noted that Fdh3 is related to bi-functional enzymes that also have formaldehyde dehydrogenase activity. Therefore we predicted that these highly conserved enzymes play differential but key roles in GSSG and GSNO recycling and formaldehyde detoxification (Fig 2), and in the maintenance of the redox homeostasis. Hence we reasoned that Glr1 and Fdh3 are probably crucial for C. albicans survival during host-pathogen interaction.

To test this, we generated C. albicans glr1Δ and fdh3Δ null mutants and compared their phenotypes to those of wild type and reintegrant control strains. Three key observations have confirmed our predictions. Firstly, glr1Δ cells are sensitive to oxidative stress, but not to nitrosative or formaldehyde stress. Fdh3Δ cells on the other hand display sensitivity to nitrosative or formaldehyde stress, but not to oxidative stress (Fig 3). Secondly, deletion of Glr1 completely blocks GSSG detoxification, and Fdh3 deletion slows GSNO detoxification (Fig 6). Thirdly, the glutathione redox potential is significantly perturbed in glr1Δ cells (Fig 6C).

The functions of Glr1 and Fdh3 are intimately linked, for example through their recycling of glutathione adducts, and in particular by the generation of GSSG by Fdh3-mediated recycling of GSNO (Fig 2). This linkage is reflected in several observations. For example, compensatory changes in GLR1 and FDH3 gene expression occur in fdh3Δ and glr1Δ cells, respectively (Figs 3 and 4). The increased FDH3 expression in glr1Δ cells appears to result in elevated resistance to nitrosative stress (Fig 3C). Also, deletion of Glr1 leads to the induction of oxidative stress genes (TRX1) and redox-dependent protein folding functions (PDI1) in response to formaldehyde stress (Fig 5), presumably due to the excessive accumulation of GSSG under these conditions. Furthermore, deletion of Fdh3 slows GSSG detoxification (Fig 6A), presumably because GLR1 expression is reduced approximately 4-fold in fdh3Δ cells (Fig 4).

Fdh3 does not appear to be the only enzyme in C. albicans that has denitrosylation or trans-nitrosylation activity because GSNO detoxification is only partially inhibited in fdh3Δ cells (Fig 6B). Nitric oxide (NO) release and NO signalling are under tight regulatory control in eukaryotic cells [60]. GSNO can act as a cellular NO “reservoir” as it can release NO or act as a substrate for the transfer of NO to target cysteine residues via trans-nitrosylation [61]. Moreover, several types of eukaryotic enzymes in addition to GSNORs [6264] have trans-nitrosylase or denitrosylase activity, including thioredoxin [65], thioredoxin reductase [6668], superoxide dismutase 1 [69,70], haemoglobin [71] and protein-disulphide isomerase [72,73]. However, the potential roles of these systems in GSNO detoxification have not yet been defined in C. albicans. In contrast, the identity of the key NO detoxification enzyme in C. albicans has been determined. This role has been assigned to the haem oxygenase, Yhb1 [43,74,75].

Given their key roles in the maintenance of glutathione redox homeostasis, it was to be expected that Glr1 and Fdh3 influence fungus-phagocyte interactions and contribute to the virulence of C. albicans. The deletion of Glr1 or Fdh3 reduced the ability of C. albicans cells to kill macrophages, and overexpression of GLR1 or FDH3 increased the potency of C. albicans (Fig 7). Also, glr1Δ and fdh3Δ cells displayed reduced virulence in the invertebrate G. mellonella infection model, whilst GLR1 and FDH3 overexpressing cells were more virulent (Fig 8). Furthermore, in a mammalian model of systemic candidiasis, glr1Δ cells displayed attenuated virulence, and GLR1 overexpressing strain showed increased virulence (Fig 9). However, the behaviour of FDH3 mutants differed between the invertebrate and mammalian models, fdh3Δ cells displaying no significant reduction in virulence and FDH3 overexpressing cells having reduced virulence.

Why might fdh3Δ and FDH3 over-expressing cells display differences in their virulence phenotypes between the G. mellonella and murine infection models? A number of studies have shown that there is a good correlation between the outcome of insect and mouse infection models [7678]. However, this might not always be the case. Possible differences in the NO concentrations experienced by C. albicans cells in these infection models might account for the differential impact of FDH3 mutations. However, Bergin et al. (2005) have reported that the G. mellonella haemocytes act in a similar fashion to human neutrophils in that they are able to phagocytose bacteria and fungi and generate superoxide [7981]. Alternatively, the differential virulence phenotypes for FDH3 mutants might relate to the impact of FDH3 upon GLR1 expression (Figs 4 and 5). This might be significant in the context of the strong oxidising potential of mouse immune cells, and the complexity of mammalian niches [46].

Why might fdh3Δ cells, but not glr1Δ cells display contrasting phenotypes in the invertebrate and mammalian infection models? The basis for this probably lies in the observation that glr1Δ cells have a lower glutathione redox buffering capacity than fdh3Δ cells (Fig 6C). Therefore, glr1Δ cells are more vulnerable to ROS or RNS than fdh3Δ cells. Nevertheless, despite the complexities of FDH3 virulence phenotypes, it is clear that FHD3 and GLR1 functionality strongly influences C. albicans pathogenicity.

To conclude, this study has demonstrated that Glr1 and Fdh3 play important roles in oxidative, nitrosative and formaldehyde stress response in C. albicans, and that this contributes to C. albicans pathogenicity. Our findings emphasise the importance of the glutathione system and the key role of enzymes involved in the maintenance of intracellular redox homeostasis during host infection.

Materials and Methods

Strains and growth conditions

C. albicans strains (Table 1) were grown at 30°C in YPDT (2% glucose, 2% Mycological peptone, 1% yeast extract, 100 mM Tris-HCl, pH 7.4) [82], or SD [83] supplemented with Complete Supplement (CSM) Drop-out mixture lacking uracil/uridine or arginine (Formedium). Nourseothricin was added to a final concentration of 200 μg/mL.

Stress conditions

To examine stress responses, C. albicans cells were grown overnight at 30°C and 200 rpm in YPDT. Cells were then re-inoculated into YPDT to an OD600 of 0.2 and grown to an OD600 of 0.8 at 30°C and 200 rpm. Cultures were then diluted four-fold in fresh YPDT, mixed with the appropriate stressors, and incubated at 30°C and 200 rpm. Stress was imposed using 1 M NaCl, 5 mM formaldehyde, 5 mM H2O2, 2.5 mM DPTA NONOate, or 2.5 mM freshly generated CysNO [82].

To examine oxidative and formaldehyde stress resistance, serial two-fold dilutions of C. albicans cells were plated onto YPD plates supplemented with 7.5 mM H2O2 or 5 mM formaldehyde. Plates were incubated for 48 h at 30°C. Results shown are representative of data from at least three independent experiments. Formaldehyde sensitivity was also tested by growth at 30°C in YPD containing a range of formaldehyde concentrations using 96 well microtiter plates. Plates were incubated with shaking at 30°C, and growth assessed relative to untreated controls by measuring the OD620 after 48 h. Experiments were performed in triplicate and one representative experiment was shown.

Nitrosative stress resistance was assessed by measuring adaptation times. Strains were grown overnight in 10 mL YPDT at 30°C, and diluted to an OD600 of 0.1 in fresh YPDT. Aliquots (100 μL) were added to 96 well microtiter plates (Costar) containing 100 μL YPDT containing 5 mM DPTA NONOate or CysNO (final concentration 2.5 mM). Plates were incubated with shaking at 30°C and the OD620 measured every 20 min for 48–72 h in a FluroStar Optima plate reader (BMG Labtech). Stress adaptation times were determined by measuring the inflection times for each growth curve, as described previously [84]. Data represent the means and standard deviations from at least three independent experiments.

To prepare CysNO, 4 mL of 0.34 mM L-cysteine, 0.75 M HCl was added to 5 mL of 0.5 mM NaNO2. After the solution turned deep red, 2.5 mL 1 M NaOH was added and the concentration of CysNO measured at 335 nm (ε335nm 503 M-1cm-1) [85].

Plasmid and strain construction

To generate fdh3Δ null mutants, the two FDH3 alleles in C. albicans BWP17 (Table 1) were sequentially disrupted using fdh3Δ::loxP-ARG4-loxP and fdh3Δ::loxP-URA3-loxP markers [86] that were PCR amplified using the primers described in S1 Table. This generated the heterozygous mutant fdh3Δ::LAL/FDH3 (ATT0) and then the homozygous fdh3Δ::LAL/fdh3Δ::LUL null mutant (ATT1) (Table 1). To construct the reintegrant control, the FDH3 gene was PCR amplified (S1 Table), cloned into CIp30 [86,87], and the resulting CIp30-FDH3 plasmid digested with StuI and integrated at the RPS1 locus of C. albicans ATT1 to generate the fdh3Δ/fdh3Δ/FDH3 reintegrant strain, ATT4 (Table 1). The genotype of these strains was confirmed by diagnostic PCR using primers described in S1 Table.

To construct glr1Δ null strains, glr1Δ::ARG4 and glr1Δ::HIS1 disruption cassettes were generated by PCR amplification (S1 Table) from plasmids pFA-HIS1 and pFA-ARG4 [11]. The disruption cassettes were transformed into BWP17 to generate a glr1Δ::ARG4/glr1Δ::HIS1 strain. To generate the reintegrant control, the GLR1 gene was PCR amplified (S1 Table) and cloned into pLUBP [88] to make pLUBP-GLR1 (URA3). The empty pLUBP and pLUBP-GLR1 plasmids were linearized with XhoI/PacI and transformed into the glr1Δ::ARG4/glr1Δ::HIS1 to create the glr1Δ::ARG4/glr10Δ::HIS1 URA3 (CKS10) and glr1Δ::ARG4/glr1Δ::HIS1 URA3-GLR1 strains (CKS31) (Table 1).

The doxycycline-conditional over-expression strains tetON-GLR1 (ATT6) and tetON-FDH3 (ATT7) were generated as described previously [48,89]. The CIp10-based tetON expression plasmids were linearized with StuI, and transformed into C. albicans CEC2175 (Table 1). The genotypes of these strains were confirmed by diagnostic PCR using the primers described in S1 Table.

Transcript analyses

C. albicans cells were harvested, flash-frozen in liquid N2, and RNA extracted as described previously [90,91]. RNA integrity was confirmed using Bioanalyzer RNA 6000 Nano Assay Protocol according to the manufacturer’s instructions (Agilent; Stockport, UK) [92]. cDNA was prepared using Superscript II as per the manufacturer’s protocols (Invitrogen Ltd.; Paisley, UK). Transcript levels were measured by qRT-PCR relative to the internal ACT1 mRNA control using the primers listed in S1 Table with a LightCycler480 system (Roche Applied Science) using the Roche Universal Probe library [15]. Data represent the means and standard deviations from at least three independent experiments.

GSH, GSSG and GSNO assays

C. albicans cells were harvested [82] and protein extracts prepared in 0.5 M citrate, pH 5.0) as GSNO was found to be unstable at pH 8.0. For GSNO assays, 5 μL of 1 mM NADH and 10 μL of 250 μM GSNO were added to 10 μL of protein extract, and samples were derivatized at 0, 2, 5, 10, 20 and 30 min. For GSSG assays, 5 μL of 1 mM NADPH and 10 μL of 250 μM GSSG were added to 10 μL of protein extract, and samples were derivatized at 0, 2, 5, 10, 20 and 30 min. The derivatization and analysis were performed as previously described [93] using a Thermo Surveyor LC system coupled to a TSQ Quantum, triple quadrupole mass spectrometer (Thermo Scientific, UK). The following SRM transitions were used for quantification; Glu-Glu (internal standard) m/z 277–241, GSNO m/z 337–307, GSNEM m/z 433–304 and GSSG m/z 613–355. Peak integration and quantification was performed using Xcalibur software (Version 2.0.7.SP2). GSH, GSSG and GSNO concentrations were then calculated relative to authentic standards. Data were normalised against total protein. Data represent the means and standard deviations from at least three independent experiments.

The redox potential was calculated using the GSH and GSSG concentrations calculated using the following equation based on the Nernst equation [20].

(30°C, pH 7.4)

Macrophage killing assay

RAW264.7 murine macrophages were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum. C. albicans cells (1x106) were co-incubated with RAW264.7 macrophages (2x105) for 3 h at 37°C. For doxycycline-induced over-expression, C. albicans cells were prepared by growing overnight in YPDT containing 100 μg/mL doxycycline. Wells were washed with PBS and stained with trypan blue. Macrophages were fixed in 3% formaldehyde for 3 min and images were recorded with an Zeiss Axio Observer Z1 inverted microscope and Zeiss Hrm camera. Images were analysed using Axiovision 4.8.2 software, and the percentage of killed macrophages calculated by analysing at least 200 macrophages per well [94]. All data were generated in triplicate for at least three independent experiments and one representative experiment was represented.

Galleria mellonella virulence assay

The virulence of C. albicans strains was assessed using groups of 20 G. mellonella larvae (Livefoods, UK) in the sixth instar as described previously [95]. C. albicans inocula were grown in YPDT at 30°C overnight with agitation. For doxycycline-induced over-expression, 100 μg/mL doxycycline was added to the medium. C. albicans cells were washed three times in PBS, re-suspended in PBS at 2.5 x 105 cells/mL and 10 μL of suspension injected via the last proleg [95]. Untouched larvae and larvae injected with PBS +/- doxycycline served as controls. After injection larvae were incubated at 37°C and the number of dead larvae scored every 12 h. Statistical analyses were performed using the Kaplan-Meier log rank test. Differences with a P value < 0.05 were considered significant. Three independent experiments were performed, and data from one representative experiment are presented.

Murine virulence assay

The three-day murine intravenous challenge model of C. albicans infection [50] was used to determine the impact of GLR1 and FDH3 upon virulence. Female BALB/c mice (6–8 weeks old; Harlan, UK) were randomly assigned into groups of six mice, were housed in individually ventilated cages (IVCs) and were provided with food and drinking fluid ad libitum. Each group of mice was inoculated via the lateral tail vein with C. albicans cells (3 x 104 CFU g-1 mouse body weight) grown at 30°C in NGY +/- 50 μg/mL doxycycline [96]. The fungal inoculum used for each mouse group was also randomised. For doxycycline treated mice, mice were either provided with 5% sucrose or 5% sucrose containing 2 mg/mL doxycycline as their drinking fluid. Mice were monitored and weighed daily. After 72 h, mice were weighed, terminated by cervical dislocation, and renal fungal burdens determined. The outcome score [50] was calculated based on the fungal kidney burdens and percentage weight change at 72 h. Statistical differences between body weight changes, kidney burdens and outcome scores were determined by Kruskall-Wallis and Mann-Whitney U tests using IBM SPSS (version 20).

Ethics statement

All animal experimentation was performed under UK Home Office Project license 60/4135 and was approved by the UK Home Office and by the Animal Welfare and Ethical Review Body of the University of Aberdeen. All work conformed to European Directive 2010/63/EU.

Animals were carefully monitored for signs of distress during the infection studies. Distress was minimised by expert handling. Animals were weighed once daily, and monitored for changes in condition at least twice daily. Animals were euthanized humanely by cervical dislocation when they showed signs of severe illness, i.e. they had a ruffled coat, displayed a hunched posture, were unwilling to move around the cage and had lost 20% of their initial body weight. There were no unexpected incidents of mortality during this study. Analgesia and anaesthetics were not required.

Statistical analyses

Unless otherwise stated, data are expressed as means plus standard deviations from at least three independent experiments: * p< 0.05; ** p<0.001; and *** p <0.0001. Statistical significance was determined by one-way ANOVA with post hoc analysis using Dunnett's t-tests with a 95% confidence level. Analyses were carried out using Prism 5.0 (Graphpad). Data are represented in means ± SD.

Supporting Information

S1 Fig. Candida albicans GLR1 encodes a NADPH-dependent glutathione reductase.

The sequence alignment of homologs of the NADPH-dependent glutathione reductase GLR1 (C5_01520C) was generated using ClustalW. The homologs from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Mus musculus, Homo sapiens and Caenorhabditis elegans used for the multiple sequence alignments were obtained from NCBI/ BLAST are shown. The conserved NADH binding domain within a larger FAD bindingdomain and the C-terminal dimerisation domain are illustrated in red and green, respectively.

https://doi.org/10.1371/journal.pone.0126940.s001

(TIF)

S2 Fig. Candida albicans FDH3 encodes a GSH-dependent formaldehyde dehydrogenase class III.

The sequence alignment of homologs of the Candida albicans GSH-dependent formaldehyde dehydrogenase FDH3 (CR_10250C_A) was generated using ClustalW. The homologs from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Mus musculus, Homo sapiens, Drosophila melanogaster and Caenorhabditis elegans used for the multiple sequence alignments were obtained from NCBI/ BLAST are shown. The conserved catalytic domain of the alcohol dehydrogenases class III and the C-terminal cofactor-binding domain that reversibly binds NAD(H) are illustrated in red and green, respectively.

https://doi.org/10.1371/journal.pone.0126940.s002

(TIF)

S1 Table. PCR Primers.

https://doi.org/10.1371/journal.pone.0126940.s003

(DOCX)

Acknowledgments

We thank Aaron Mitchell and Dominique Sanglard for providing the C. albicans protein kinase and transposon mutant libraries, and Louise Walker for the strain CAMY203.

Author Contributions

Conceived and designed the experiments: ATT KS DMM NARG BD AJPB. Performed the experiments: ATT KS GC DMM. Analyzed the data: ATT KS DMM BD AJPB. Contributed reagents/materials/analysis tools: KS BD ER CAM MT. Wrote the paper: ATT KS BD DMM NARG AJPB.

References

  1. 1. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321–46. pmid:17510856.
  2. 2. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. pmid:23253612.
  3. 3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–17. pmid:15306996.
  4. 4. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011;89(6):873–91. pmid:21233414; PubMed Central PMCID: PMC3100761.
  5. 5. Reeves EP, Lu H, Lortat-Jacob H, Messina CGM, Bolsover S, Gabella G, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416(6878):291–7. WOS:000174482200034. pmid:11907569
  6. 6. Roos D, van Bruggen R, Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect. 2003;5(14):1307–15. pmid:14613774.
  7. 7. Gross NT, Nessa K, Camner P, Jarstrand C. Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus. Med Mycol. 1999;37(3):151–7. pmid:10421846.
  8. 8. Carlos IZ, Silva Monnazzi LG, Falcao DP, Machado de Medeiros BM. TNF-alpha, H2O2 and NO response of peritoneal macrophages to Yersinia enterocolitica O:3 derivatives. Microbes Infect. 2004;6(2):207–12. pmid:14998520.
  9. 9. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun. 1992;60(1):1–7. pmid:1729174; PubMed Central PMCID: PMC257494.
  10. 10. Nusse O. Biochemistry of the phagosome: the challenge to study a transient organelle. ScientificWorldJournal. 2011;11:2364–81. Epub 2011/12/24. pmid:22194668; PubMed Central PMCID: PMC3236389.
  11. 11. Winterbourn CC. The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim Biophys Acta. 2014;1840(2):730–8. pmid:23665586.
  12. 12. Zhang Z, Dmitrieva NI, Park JH, Levine RL, Burg MB. High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA. Proc Natl Acad Sci U S A. 2004;101(25):9491–6. pmid:15190183; PubMed Central PMCID: PMC439004.
  13. 13. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC, et al. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol. 2005;56(2):397–415. pmid:15813733.
  14. 14. Enjalbert B, MacCallum DM, Odds FC, Brown AJ. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun. 2007;75(5):2143–51. pmid:17339352; PubMed Central PMCID: PMC1865731.
  15. 15. Kaloriti D, Jacobsen M, Yin Z, Patterson M, Tillmann A, Smith DA, et al. Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes. MBio. 2014;5(4):e01334–14. pmid:25028425; PubMed Central PMCID: PMC4161263.
  16. 16. Winterbourn CC, Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med. 2008;45(5):549–61. pmid:18544350.
  17. 17. Penninckx MJ. An overview on glutathione in Saccharomyces versus non-conventional yeasts. FEMS Yeast Res. 2002;2(3):295–305. pmid:12702279.
  18. 18. Grant CM, Quinn KA, Dawes IW. Differential protein S-thiolation of glyceraldehyde-3-phosphate dehydrogenase isoenzymes influences sensitivity to oxidative stress. Mol Cell Biol. 1999;19(4):2650–6. pmid:10082531; PubMed Central PMCID: PMC84058.
  19. 19. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52(1):711–60. pmid:6137189.
  20. 20. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30(11):1191–212. Epub 2001/05/23. doi: S0891584901004804 [pii]. pmid:11368918.
  21. 21. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410(6827):490–4. pmid:11260719.
  22. 22. Missall TA, Lodge JK, McEwen JE. Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts. Eukaryot Cell. 2004;3(4):835–46. pmid:15302816; PubMed Central PMCID: PMC500878.
  23. 23. Grant CM, MacIver FH, Dawes IW. Glutathione synthetase is dispensable for growth under both normal and oxidative stress conditions in the yeast Saccharomyces cerevisiae due to an accumulation of the dipeptide gamma-glutamylcysteine. Mol Biol Cell. 1997;8(9):1699–707. WOS:A1997XW99300005. pmid:9307967
  24. 24. Toledano MB, Kumar C, Le Moan N, Spector D, Tacnet F. The system biology of thiol redox system in Escherichia coli and yeast: differential functions in oxidative stress, iron metabolism and DNA synthesis. FEBS Lett. 2007;581(19):3598–607. pmid:17659286.
  25. 25. Drakulic T, Temple MD, Guido R, Jarolim S, Breitenbach M, Attfield PV, et al. Involvement of oxidative stress response genes in redox homeostasis, the level of reactive oxygen species, and ageing in Saccharomyces cerevisiae. FEMS Yeast Res. 2005;5(12):1215–28. pmid:16087409.
  26. 26. Grant CM, MacIver FH, Dawes IW. Glutathione is an essential metabolite required for resistance to oxidative stress in the yeast Saccharomyces cerevisiae. Curr Genet. 1996;29(6):511–5 WOS:A1996UP31900002. pmid:8662189
  27. 27. Kwolek-Mirek M, Zadrag-Tecza R, Bartosz G. Ascorbate and thiol antioxidants abolish sensitivity of yeast Saccharomyces cerevisiae to disulfiram. Cell Biol Toxicol. 2012;28(1):1–9. pmid:21866320; PubMed Central PMCID: PMC3247666.
  28. 28. Kwolek-Mirek M, Bartosz G, Spickett CM. Sensitivity of antioxidant-deficient yeast to hypochlorite and chlorite. Yeast. 2011;28(8):595–609. pmid:21761455.
  29. 29. Thorsen M, Perrone GG, Kristiansson E, Traini M, Ye T, Dawes IW, et al. Genetic basis of arsenite and cadmium tolerance in Saccharomyces cerevisiae. BMC Genomics. 2009;10(1):105. pmid:19284616; PubMed Central PMCID: PMC2660369.
  30. 30. Baek YU, Kim YR, Yim HS, Kang SO. Disruption of gamma-glutamylcysteine synthetase results in absolute glutathione auxotrophy and apoptosis in Candida albicans. FEBS Lett. 2004;556(1–3):47–52. pmid:14706824.
  31. 31. Yadav AK, Desai PR, Rai MN, Kaur R, Ganesan K, Bachhawat AK. Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicans. Microbiology. 2011;157(Pt 2):484–95. pmid:20966090.
  32. 32. Grant CM. Role of the glutathione/glutaredoxin and thioredoxin systems in yeast growth and response to stress conditions. Mol Microbiol. 2001;39(3):533–41. pmid:11169096.
  33. 33. Grant CM, Collinson LP, Roe JH, Dawes IW. Yeast glutathione reductase is required for protection against oxidative stress and is a target gene for yAP-1 transcriptional regulation. Mol Microbiol. 1996;21(1):171–9. WOS:A1996UX70000016. pmid:8843443
  34. 34. Tan SX, Greetham D, Raeth S, Grant CM, Dawes IW, Perrone GG. The thioredoxin-thioredoxin reductase system can function in vivo as an alternative system to reduce oxidized glutathione in Saccharomyces cerevisiae. J Biol Chem. 2010;285(9):6118–26. pmid:19951944; PubMed Central PMCID: PMC2825406.
  35. 35. Kanzok SM, Fechner A, Bauer H, Ulschmid JK, Muller HM, Botella-Munoz J, et al. Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science. 2001;291(5504):643–6. pmid:11158675.
  36. 36. Krauth-Siegel RL, Comini MA. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta. 2008;1780(11):1236–48. pmid:18395526.
  37. 37. Staab CA, Hellgren M, Hoog JO. Medium- and short-chain dehydrogenase/reductase gene and protein families: Dual functions of alcohol dehydrogenase 3: implications with focus on formaldehyde dehydrogenase and S-nitrosoglutathione reductase activities. Cell Mol Life Sci. 2008;65(24):3950–60. pmid:19011746.
  38. 38. Feechan A, Kwon E, Yun BW, Wang Y, Pallas JA, Loake GJ. A central role for S-nitrosothiols in plant disease resistance. Proc Natl Acad Sci U S A. 2005;102(22):8054–9. pmid:15911759; PubMed Central PMCID: PMC1142375.
  39. 39. Inglis DO, Arnaud MB, Binkley J, Shah P, Skrzypek MS, Wymore F, et al. The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res. 2012;40(Database issue):D667–74. pmid:22064862; PubMed Central PMCID: PMC3245171.
  40. 40. Strijbis K. Compartmentalization of metabolic pathways in Candida albicans: a matter of transport. Amsterdam: University of Amsterdam; 2009.
  41. 41. Enjalbert B, Smith DA, Cornell MJ, Alam I, Nicholls S, Brown AJ, et al. Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Mol Biol Cell. 2006;17(2):1018–32. pmid:16339080; PubMed Central PMCID: PMC1356608.
  42. 42. Enjalbert B, Nantel A, Whiteway M. Stress-induced gene expression in Candida albicans: absence of a general stress response. Mol Biol Cell. 2003;14(4):1460–7. pmid:12686601; PubMed Central PMCID: PMC153114.
  43. 43. Hromatka BS, Noble SM, Johnson AD. Transcriptional response of Candida albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and virulence. Mol Biol Cell. 2005;16(10):4814–26. pmid:16030247; PubMed Central PMCID: PMC1237085.
  44. 44. Flohe L. The fairytale of the GSSG/GSH redox potential. Biochim Biophys Acta. 2013;1830(5):3139–42. pmid:23127894.
  45. 45. Brown AJ, Haynes K, Quinn J. Nitrosative and oxidative stress responses in fungal pathogenicity. Curr Opin Microbiol. 2009;12(4):384–91. pmid:19616469; PubMed Central PMCID: PMC2728829.
  46. 46. Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol. 2011;29:1–21. Epub 2010/10/13. pmid:20936972; PubMed Central PMCID: PMC3434799.
  47. 47. Ihmels J, Bergmann S, Gerami-Nejad M, Yanai I, McClellan M, Berman J, et al. Rewiring of the yeast transcriptional network through the evolution of motif usage. Science. 2005;309(5736):938–40. pmid:16081737.
  48. 48. Chauvel M, Nesseir A, Cabral V, Znaidi S, Goyard S, Bachellier-Bassi S, et al. A versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness. PLoS One. 2012;7(9):e45912. pmid:23049891; PubMed Central PMCID: PMC3457969.
  49. 49. Li DD, Deng L, Hu GH, Zhao LX, Hu DD, Jiang YY, et al. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents. Biol Pharm Bull. 2013;36(9):1482–7. pmid:23995660.
  50. 50. MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob Agents Chemother. 2010;54(4):1476–83. pmid:20086148; PubMed Central PMCID: PMC2849354.
  51. 51. Alonso-Monge R, Navarro-Garcia F, Molero G, Diez-Orejas R, Gustin M, Pla J, et al. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J Bacteriol. 1999;181(10):3058–68. pmid:10322006; PubMed Central PMCID: PMC93760.
  52. 52. Jain C, Pastor K, Gonzalez AY, Lorenz MC, Rao RP. The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection. Virulence. 2013;4(1):67–76. pmid:23314569; PubMed Central PMCID: PMC3544750.
  53. 53. Cheetham J, MacCallum DM, Doris KS, da Silva Dantas A, Scorfield S, Odds F, et al. MAPKKK-independent regulation of the Hog1 stress-activated protein kinase in Candida albicans. J Biol Chem. 2011;286(49):42002–16. pmid:21994942; PubMed Central PMCID: PMC3234903.
  54. 54. Wysong DR, Christin L, Sugar AM, Robbins PW, Diamond RD. Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect Immun. 1998;66(5):1953–61. pmid:9573075; PubMed Central PMCID: PMC108149.
  55. 55. Hwang CS, Rhie GE, Oh JH, Huh WK, Yim HS, Kang SO. Copper- and zinc-containing superoxide dismutase (Cu/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology. 2002;148(Pt 11):3705–13. pmid:12427960.
  56. 56. Martchenko M, Alarco AM, Harcus D, Whiteway M. Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol Biol Cell. 2004;15(2):456–67. pmid:14617819; PubMed Central PMCID: PMC329211.
  57. 57. Chaves GM, Bates S, Maccallum DM, Odds FC. Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model. Genet Mol Res. 2007;6(4):1051–63. pmid:18273798.
  58. 58. Bambach A, Fernandes MP, Ghosh A, Kruppa M, Alex D, Li D, et al. Goa1p of Candida albicans localizes to the mitochondria during stress and is required for mitochondrial function and virulence. Eukaryot Cell. 2009;8(11):1706–20. pmid:19717740; PubMed Central PMCID: PMC2772395.
  59. 59. da Silva Dantas A, Patterson MJ, Smith DA, Maccallum DM, Erwig LP, Morgan BA, et al. Thioredoxin regulates multiple hydrogen peroxide-induced signaling pathways in Candida albicans. Mol Cell Biol. 2010;30(19):4550–63. pmid:20679492; PubMed Central PMCID: PMC2950526.
  60. 60. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78(6):931–6. pmid:7923362.
  61. 61. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409(6820):622–6. pmid:11214321.
  62. 62. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell. 2004;116(4):617–28. pmid:14980227.
  63. 63. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, et al. Protection from experimental asthma by an endogenous bronchodilator. Science. 2005;308(5728):1618–21. pmid:15919956; PubMed Central PMCID: PMC2128762.
  64. 64. Lima B, Lam GK, Xie L, Diesen DL, Villamizar N, Nienaber J, et al. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A. 2009;106(15):6297–302. pmid:19325130; PubMed Central PMCID: PMC2669330.
  65. 65. Benhar M, Forrester MT, Hess DT, Stamler JS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science. 2008;320(5879):1050–4. pmid:18497292; PubMed Central PMCID: PMC2754768.
  66. 66. Weichsel A, Kem M, Montfort WR. Crystal structure of human thioredoxin revealing an unraveled helix and exposed S-nitrosation site. Protein Sci. 2010;19(9):1801–6. pmid:20662007; PubMed Central PMCID: PMC2975143.
  67. 67. Mitchell DA, Marletta MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol. 2005;1(3):154–8. pmid:16408020.
  68. 68. Mitchell DA, Morton SU, Fernhoff NB, Marletta MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc Natl Acad Sci U S A. 2007;104(28):11609–14. WOS:000248063400019. pmid:17606900
  69. 69. Jourd'heuil D, Laroux FS, Miles AM, Wink DA, Grisham MB. Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys. 1999;361(2):323–30. pmid:9882463.
  70. 70. Johnson MA, Macdonald TL, Mannick JB, Conaway MR, Gaston B. Accelerated s-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutase. J Biol Chem. 2001;276(43):39872–8. pmid:11518706.
  71. 71. McMahon TJ, Doctor A. Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc. 2006;3(2):153–60. pmid:16565424; PubMed Central PMCID: PMC2658680.
  72. 72. Zai A, Rudd MA, Scribner AW, Loscalzo J. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest. 1999;103(3):393–9. pmid:9927500; PubMed Central PMCID: PMC407899.
  73. 73. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006;441(7092):513–7. pmid:16724068.
  74. 74. Ullmann BD, Myers H, Chiranand W, Lazzell AL, Zhao Q, Vega LA, et al. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell. 2004;3(3):715–23. pmid:15189992; PubMed Central PMCID: PMC420131.
  75. 75. Tillmann A, Gow NA, Brown AJ. Nitric oxide and nitrosative stress tolerance in yeast. Biochem Soc Trans. 2011;39(1):219–23. pmid:21265777; PubMed Central PMCID: PMC3615668.
  76. 76. Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol. 2002;34(2):153–7. Epub 2002/10/17. doi: S0928824402003747 [pii]. pmid:12381467.
  77. 77. Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. Journal of Bacteriology. 2000;182(13):3843–5. WOS:000087602900032. pmid:10851003
  78. 78. Salamitou S, Ramisse F, Brehelin M, Bourguet D, Gilois N, Gominet M, et al. The plcR regulon is involved in the opportunistic properties of Bacillus thuringiensis and Bacillus cereus in mice and insects. Microbiology. 2000;146 (Pt 11):2825–32. Epub 2000/11/07. pmid:11065361.
  79. 79. Bergin D, Reeves EP, Renwick J, Wientjes FB, Kavanagh K. Superoxide production in Galleria mellonella hemocytes: identification of proteins homologous to the NADPH oxidase complex of human neutrophils. Infect Immun. 2005;73(7):4161–70. pmid:15972506; PubMed Central PMCID: PMC1168619.
  80. 80. Lavine MD, Strand MR. Insect hemocytes and their role in immunity. Insect Biochem Mol Biol. 2002;32(10):1295–309. WOS:000178570300012. pmid:12225920
  81. 81. Renwick J, Reeves EP, Wientjes FB, Kavanagh K. Translocation of proteins homologous to human neutrophil p47phox and p67phox to the cell membrane in activated haemocytes of Galleria mellonella. Dev Comp Immunol. 2007;31(4):347–59. pmid:16920193
  82. 82. Kaloriti D, Tillmann A, Cook E, Jacobsen M, You T, Lenardon M, et al. Combinatorial stresses kill pathogenic Candida species. Med Mycol. 2012;50(7):699–709. Epub 2012/04/03. pmid:22463109; PubMed Central PMCID: PMC3483063.
  83. 83. Sherman F. Getting started with yeast. Methods Enzymol. 2002;350:3–41. pmid:12073320.
  84. 84. Zwietering MH, Jongenburger I, Rombouts FM, van 't Riet K. Modeling of the bacterial growth curve. Appl Environ Microbiol. 1990;56(6):1875–81. pmid:16348228; PubMed Central PMCID: PMC184525.
  85. 85. Bechtold E, Reisz JA, Klomsiri C, Tsang AW, Wright MW, Poole LB, et al. Water-soluble triarylphosphines as biomarkers for protein S-nitrosation. ACS Chem Biol. 2010;5(4):405–14. pmid:20146502; PubMed Central PMCID: PMC2863053.
  86. 86. Dennison PM, Ramsdale M, Manson CL, Brown AJ. Gene disruption in Candida albicans using a synthetic, codon-optimised Cre-loxP system. Fungal Genet Biol. 2005;42(9):737–48. Epub 2005/07/27. pmid:16043373.
  87. 87. Murad AM, Lee PR, Broadbent ID, Barelle CJ, Brown AJ. CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast. 2000;16(4):325–7. pmid:10669870.
  88. 88. Ramon AM, Fonzi WA. Diverged binding specificity of Rim101p, the Candida albicans ortholog of PacC. Eukaryot Cell. 2003;2(4):718–28. pmid:12912891; PubMed Central PMCID: PMC178344.
  89. 89. Cabral V, Chauvel M, Firon A, Legrand M, Nessier A, Bachellier-Bassi S, et al. Modular Gene Over-expression Strategies for Candida albicans. In: Brand AC, MacCallum DM, editors. Methods Mol Biol. 845: Springer Protocols; 2012. p. 227–44. pmid:22328378
  90. 90. Hauser NC, Vingron M, Scheideler M, Krems B, Hellmuth K, Entian KD, et al. Transcriptional profiling on all open reading frames of Saccharomyces cerevisiae. Yeast. 1998;14(13):1209–21. WOS:000076263800006. pmid:9791892
  91. 91. Hayes A, Zhang N, Wu J, Butler PR, Hauser NC, Hoheisel JD, et al. Hybridization array technology coupled with chemostat culture: Tools to interrogate gene expression in Saccharomyces cerevisiae. Methods. 2002;26(3):281–90. pmid:12054884.
  92. 92. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005;33(6):e56. pmid:15800207; PubMed Central PMCID: PMC1072807.
  93. 93. Steghens JP, Flourie F, Arab K, Collombel C. Fast liquid chromatography-mass spectrometry glutathione measurement in whole blood: micromolar GSSG is a sample preparation artifact. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;798(2):343–9. WOS:000187731800021. pmid:14643515
  94. 94. McKenzie CG, Koser U, Lewis LE, Bain JM, Mora-Montes HM, Barker RN, et al. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun. 2010;78(4):1650–8. pmid:20123707; PubMed Central PMCID: PMC2849426.
  95. 95. Hall RA, Bates S, Lenardon MD, Maccallum DM, Wagener J, Lowman DW, et al. The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathog. 2013;9(4):e1003276. pmid:23633946; PubMed Central PMCID: PMC3636026.
  96. 96. MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses. 2005;48(3):151–61. Epub 2005/04/22. pmid:15842329.
  97. 97. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, et al. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J. 2001;20(17):4742–52. pmid:11532938; PubMed Central PMCID: PMC125592.
  98. 98. Brand A, MacCallum DM, Brown AJP, Gow NAR, Odds FC. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryotic Cell. 2004;3(4):900–9. WOS:000223418000009. pmid:15302823
  99. 99. Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics. 1993;134(3):717–28. pmid:8349105; PubMed Central PMCID: PMC1205510.
  100. 100. Negredo A, Monteoliva L, Gil C, Pla J, Nombela C. Cloning, analysis and one-step disruption of the ARG5,6 gene of Candida albicans. Microbiology. 1997;143 (Pt 2)(2):297–302. pmid:9043106.
  101. 101. Smith DA, Nicholls S, Morgan BA, Brown AJ, Quinn J. A conserved stress-activated protein kinase regulates a core stress response in the human pathogen Candida albicans. Mol Biol Cell. 2004;15(9):4179–90. pmid:15229284; PubMed Central PMCID: PMC515350.
  102. 102. Wilson RB, Davis D, Mitchell AP. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol. 1999;181(6):1868–74. WOS:000079146700022. pmid:10074081